kINPen MED®

Chapter

Abstract

This chapter introduces the cold atmospheric pressure argon plasma jet kINPen® MED. This plasma source received approval as medical device class IIa from the supervisory boards in Germany. The plasma jet is generated by a DC power of maximum 8 VA (110/230 V, 50/60 Hz) using argon as working gas. The purpose of the device is the treatment of chronic wounds as well as pathogen-based diseases of skin, skin appandages, extremities and body. More details and contact information is available on the company website: www.neoplas-tools.eu.

Keywords

Atmospheric pressure plasma jet Cold atmospheric plasma (CAP) Medical device class IIa Plasma medicine Decontamination Wound-healing 

References

  1. 1.
    Weltmann KD, von Woedtke T, Brandenburg R, Ehlbeck J. Biomedical applications of atmospheric pressure plasma. Chem List. 2008;102:1450–1.Google Scholar
  2. 2.
    Weltmann KD, Kindel E, Brandenburg R, Meyer C, Bussiahn R, Wilke C, von Woedtke T. Atmospheric pressure plasma jet for medical therapy: plasma parameters and risk estimation. Contrib Plasma Phys. 2009;49:631.CrossRefGoogle Scholar
  3. 3.
    Weltmann KD, von Woedtke T. Basic requirements for plasma sources in medicine. Eur Phys J Appl Phys. 2011;55:13804.CrossRefGoogle Scholar
  4. 4.
    Bekeschus S, Schmidt A, Weltmann KD, von Woedtke T. The plasma jet kINPen—a powerful tool for wound healing. Clin Plasma Med. 2016;4:19–28.CrossRefGoogle Scholar
  5. 5.
    Daeschlein G, Scholz S, Ahmed R, von Woedtke T, Haase H, Niggemeier M, Kindel E, Brandenburg R, Weltmann KD, Juenger M. Skin decontamination by low-temperature atmospheric pressure plasma jet and dielectric barrier discharge plasma. J Hosp Infect. 2012;81:177–83.CrossRefGoogle Scholar
  6. 6.
    Daeschlein G, Napp M, von Podwils S, Lutze S, Emmert S, Lange A, Klare I, Haase H, Gümbel D, von Woedtke T, Jünger M. In vitro susceptibility of multidrug resistant skin and wound pathogens against low-temperature atmospheric pressure plasma jet (appj) and dielectric barrier discharge plasma (dbd). Plasma Process Polym. 2014;11:175–83.CrossRefGoogle Scholar
  7. 7.
    Wende K, Reuter S, von Woedtke T, Weltmann KD, Masur K. Redox-based assay for assessment of biological impact of plasma treatment. Plasma Process Polym. 2014;11:655–63.CrossRefGoogle Scholar
  8. 8.
    Kramer A, Lademann J, Bender CP, Sckell A, Hartmann B, Münch S. Suitability of tissue tolerable plasma (TTP) for the management of chronic wounds. Clin Plasma Med. 2013;1:11–8.CrossRefGoogle Scholar
  9. 9.
    Barton A, Wende K, Bundscherer L, Hasse S, Schmidt A, Bekeschus S, Weltmann KD, Lindquist U, Masur K. Nonthermal plasma increases expression of wound healing in a keratinocyte cell line. Plasma Med. 2013;3:125–36.CrossRefGoogle Scholar
  10. 10.
    Barker JH, Kjolseth D, Kim M, Frank J, Bondar I, Uhl E, Kamler M, Messmer K, Tobin GR, Weiner LJ. The hairless mouse ear: an in vivo model for studying wound neovascularization. Wound Repair Regen. 1994;2:138–43.CrossRefGoogle Scholar
  11. 11.
    Schmidt A, Bekeschus S, Wende K, Vollmar B, von Woedtke T. Cold plasma jet accelerates wound healing in a murine model of full—thickness skin. Exp Dermatol. 2017;26:156–62.CrossRefGoogle Scholar
  12. 12.
    Abu-Sirhan S, Hertel M, Preissner S, Wirtz HC, Herbst SR, Pierdzioch P, Raguse JD, Hartwig S. Bactericidal efficacy of cold plasma in processed bone. A new approach for adjuvant therapy of medication-related osteonecrosis of the jaw? Clin Plasma Med. 2016;4:9–13.CrossRefGoogle Scholar
  13. 13.
    Herbst SR, Hertel M, Ballout H, Pierdzioch P, Weltmann K-D, Wirtz HC, Abu-Sirhan S, Kostka E, Paris S, Preissner S. Bactericidal efficacy of cold plasma at different depths of infected root canals in vitro. Open Dent J. 2015;9:486–91.CrossRefGoogle Scholar
  14. 14.
    Preissner S, Kastner I, Schütte E, Hartwig S, Schmidt-Westhausen AM, Paris S, Preissner R, Hertel M. Adjuvant antifungal therapy using tissue tolerable plasma on oral mucosa and removable dentures in oral candidiasis patients: a randomised double-blinded split-mouth pilot study. Mycoses. 2016;59:467–75.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Neoplas Tools GmbHGreifswaldGermany

Personalised recommendations